Literature DB >> 19251416

Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.

Nicholas A Meanwell1, Owen B Wallace, Haiquan Fang, Henry Wang, Milind Deshpande, Tao Wang, Zhiwei Yin, Zhongxing Zhang, Bradley C Pearce, Jennifer James, Kap-Sun Yeung, Zhilei Qiu, J J Kim Wright, Zheng Yang, Lisa Zadjura, Donald L Tweedie, Suresh Yeola, Fang Zhao, Sunanda Ranadive, Brett A Robinson, Yi-Fei Gong, Hwei-Gene Heidi Wang, Timothy P Spicer, Wade S Blair, Pei-Yong Shi, Richard J Colonno, Pin-Fang Lin.   

Abstract

The effects of introducing simple halogen, alkyl, and alkoxy substituents to the 4, 5, 6 and 7 positions of 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione, an inhibitor of the interaction between HIV gp120 and host cell CD4 receptors, on activity in an HIV entry assay was examined. Small substituents at C-4 generally resulted in increased potency whilst substitution at C-7 was readily tolerated and uniformly produced more potent HIV entry inhibitors. Substituents deployed at C-6 and, particularly, C-5 generally produced a modest to marked weakening of potency compared to the prototype. Small alkyl substituents at N-1 exerted minimal effect on activity whilst increasing the size of the alkyl moiety led to progressively reduced inhibitory properties. These studies establish a basic understanding of the indole element of the HIV attachment inhibitor pharmacophore.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251416     DOI: 10.1016/j.bmcl.2009.02.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions.

Authors:  Arne Schön; Sonia Y Lam; Ernesto Freire
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

2.  Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules.

Authors:  Christopher G Parker; Markus K Dahlgren; Ran N Tao; Don T Li; Eugene F Douglass; Takuji Shoda; Navneet Jawanda; Krasimir A Spasov; Sangil Lee; Nannan Zhou; Robert A Domaoal; Richard E Sutton; Karen S Anderson; William L Jorgensen; Mark Krystal; David A Spiegel
Journal:  Chem Sci       Date:  2014-06-01       Impact factor: 9.825

3.  Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.

Authors:  Radhika Vangala; Sree Kanth Sivan; Saikiran Reddy Peddi; Vijjulatha Manga
Journal:  J Comput Aided Mol Des       Date:  2019-12-02       Impact factor: 3.686

4.  Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors.

Authors:  Shinichi Sato; Tsubasa Inokuma; Nobumasa Otsubo; Dennis R Burton; Carlos F Barbas
Journal:  ACS Med Chem Lett       Date:  2013-05-09       Impact factor: 4.345

5.  Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.

Authors:  David R Langley; S Roy Kimura; Prasanna Sivaprakasam; Nannan Zhou; Ira Dicker; Brian McAuliffe; Tao Wang; John F Kadow; Nicholas A Meanwell; Mark Krystal
Journal:  Proteins       Date:  2014-12-23

6.  Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold HIV-1 Entry Inhibitor.

Authors:  Megan E Meuser; Adel A Rashad; Gabriel Ozorowski; Alexej Dick; Andrew B Ward; Simon Cocklin
Journal:  Molecules       Date:  2019-04-22       Impact factor: 4.411

Review 7.  Development of Azaindole-Based Frameworks as Potential Antiviral Agents and Their Future Perspectives.

Authors:  J B Senthil Kumar; Parthasarathi Das; Vibha Tandon
Journal:  J Med Chem       Date:  2022-04-28       Impact factor: 8.039

8.  Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.

Authors:  Yen-Ting Lai; Tao Wang; Sijy O'Dell; Mark K Louder; Arne Schön; Crystal S F Cheung; Gwo-Yu Chuang; Aliaksandr Druz; Bob Lin; Krisha McKee; Dongjun Peng; Yongping Yang; Baoshan Zhang; Alon Herschhorn; Joseph Sodroski; Robert T Bailer; Nicole A Doria-Rose; John R Mascola; David R Langley; Peter D Kwong
Journal:  Nat Commun       Date:  2019-01-03       Impact factor: 14.919

Review 9.  Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell
Journal:  Med Chem Res       Date:  2021-09-28       Impact factor: 1.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.